Close Menu

You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.

Home » Business, Policy & Funding » Business News » Epic Sciences, Predicine to Offer Liquid Biopsy Service for Biopharma Customers

Epic Sciences, Predicine to Offer Liquid Biopsy Service for Biopharma Customers

Oct 29, 2020
|
staff reporter

NEW YORK – Epic Sciences and Predicine said Thursday that they have entered into a global strategic partnership to offer biopharmaceutical companies access to liquid biopsy testing via both Predicine's circulating tumor DNA technology and Epic's circulating tumor cell platform.

Financial terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Scan

Mouse Vision Restored

A Harvard-led team reprogrammed DNA methylation patterns of mice with eye problems to restore their sight, AFP reports.

Side Effect Suit in India

A man in India is suing the Serum Institute of India, saying that he suffered serious side effects from a vaccine it is testing, but the institute has rejected those claims, the Economic Times reports.

Kids' Vaccine Trial Planned

The New York Times reports Moderna is planning a clinical trial of its SARS-CoV-2 vaccine in children.

Nature Papers Present Tool for Targeted Nanopore Sequencing, Crop Genetic Diversity, More

In Nature this week: Readfish tool for targeted nanopore sequencing, genomic diversity of barley and wheat, and more.

What's Popular?

In Business News

  1. Illumina, New York Healthcare Providers, NYGC Partner on Clinical Whole-Genome Sequencing

  2. Aetna Updates Noninvasive Prenatal Testing Coverage Policy to Include All Pregnancies

  3. Swedish Sequencing Firm Single Technologies Raises $6.1M

  4. NanoString Technologies Reveals New High-Resolution Spatial Omics Platform Due 2022

    Premium

  5. Twist Bioscience Proposes $250M Public Offering

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.